These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Secretin and insulin release in acromegaly. Chisholm DJ; Lazarus L; Young JD J Clin Endocrinol Metab; 1972 Jul; 35(1):108-12. PubMed ID: 5032508 [No Abstract] [Full Text] [Related]
10. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly. Rieu M; Girard F; Bricaire H; Binoux M J Clin Endocrinol Metab; 1982 Jul; 55(1):147-53. PubMed ID: 7042736 [No Abstract] [Full Text] [Related]
11. [Insulin, glucagon and C-peptide content in the blood of acromegaly patients]. Molitvoslovova NN Probl Endokrinol (Mosk); 1983; 29(3):21-4. PubMed ID: 6346317 [TBL] [Abstract][Full Text] [Related]
12. [Somatotrophic response to hypoglycemic stimulus in patients with acromegaly. Effect of bromocriptine]. Fiszlejder L; Bokser L; Puyo AM; Chervin AB; Guitelman A Medicina (B Aires); 1986; 46(1):16-24. PubMed ID: 3543606 [No Abstract] [Full Text] [Related]
13. Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly. Hattori N; Shimatsu A; Kato Y; Koshiyama H; Ishikawa Y; Assadian H; Tanoh T; Nagao M; Imura H J Clin Endocrinol Metab; 1990 Mar; 70(3):771-6. PubMed ID: 2106529 [TBL] [Abstract][Full Text] [Related]
14. Chlorpromazine treatment and growth hormone secretory responses in acromegaly. Dimond RC; Bramer SR; Atkinson RL; Howard WJ; Earll JM J Clin Endocrinol Metab; 1973 Jun; 36(6):1189-95. PubMed ID: 4706207 [No Abstract] [Full Text] [Related]
15. Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patients. Peracchi M; Reschini E; Cantalamessa L; Giustina G; Cavagnini F; Pinto M; Bulgheroni P Metabolism; 1974 Nov; 23(11):1009-15. PubMed ID: 4418535 [No Abstract] [Full Text] [Related]
16. Serum human growth hormone (HGH) response to IV glucose: diagnosis of acromegaly in females and males. Boden G; Soeldner JS; Steinke J; Thorn GW Metabolism; 1968 Jan; 17(1):1-9. PubMed ID: 5638674 [No Abstract] [Full Text] [Related]
17. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly. Faglia G; Beck-Peccoz P; Ferrari C; Travaglini P; Ambrosi B; Spada A J Clin Endocrinol Metab; 1973 Jun; 36(6):1259-62. PubMed ID: 4196265 [No Abstract] [Full Text] [Related]
18. Effect of dexamethasone on plasma growth hormone levels in acromegaly. Nakagawa K; Horiuchi Y; Mashimo K J Clin Endocrinol Metab; 1970 Nov; 31(5):502-6. PubMed ID: 4919042 [No Abstract] [Full Text] [Related]
19. Serum leptin levels in acromegaly--a significant role for adipose tissue and fasting insulin/glucose ratio. Bolanowski M; Milewicz A; Bidzińska B; Jedrzejuk D; Daroszewski J; Mikulski E Med Sci Monit; 2002 Oct; 8(10):CR685-9. PubMed ID: 12388920 [TBL] [Abstract][Full Text] [Related]
20. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses. Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]